MX9702058A - Tratamiento y profilaxis de pancreatitis. - Google Patents

Tratamiento y profilaxis de pancreatitis.

Info

Publication number
MX9702058A
MX9702058A MX9702058A MX9702058A MX9702058A MX 9702058 A MX9702058 A MX 9702058A MX 9702058 A MX9702058 A MX 9702058A MX 9702058 A MX9702058 A MX 9702058A MX 9702058 A MX9702058 A MX 9702058A
Authority
MX
Mexico
Prior art keywords
pancreatitis
therapeutic agents
hydrogen atom
acyl group
group
Prior art date
Application number
MX9702058A
Other languages
English (en)
Other versions
MXPA97002058A (es
Inventor
Toshihiko Fujiwara
Hiroyoshi Horikoshi
Masaharu Fukami
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MX9702058A publication Critical patent/MX9702058A/es
Publication of MXPA97002058A publication Critical patent/MXPA97002058A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catching Or Destruction (AREA)

Abstract

Sensibilizadores de insulina, especialmente compuestos de tiazolidinodiona, tales como troglitazona, son utiles para el tratamiento y prevencion de pancreatitis.
MXPA/A/1997/002058A 1996-03-18 1997-03-18 Tratamiento y profilaxis de pancreatitis MXPA97002058A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP08-061063 1996-03-18
JP6106396 1996-03-18
JP25020196 1996-09-20
JP08-250201 1996-09-20

Publications (2)

Publication Number Publication Date
MX9702058A true MX9702058A (es) 1998-03-31
MXPA97002058A MXPA97002058A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
DK0796618T3 (da) 2002-05-06
AU1628597A (en) 1997-09-25
PT796618E (pt) 2002-06-28
HUP9700598A2 (hu) 1998-09-28
EP0796618B1 (en) 2002-01-30
CZ283968B6 (cs) 1998-07-15
HU9700598D0 (en) 1997-05-28
CN1170575A (zh) 1998-01-21
TW548102B (en) 2003-08-21
HUP9700598A3 (en) 1998-10-28
ID16266A (id) 1997-09-18
DE69710111T2 (de) 2002-10-02
CN1178657C (zh) 2004-12-08
NO971219L (no) 1997-09-19
CA2200126A1 (en) 1997-09-18
IL120443A0 (en) 1997-07-13
CA2200126C (en) 2006-08-15
EP0796618A1 (en) 1997-09-24
AU708315B2 (en) 1999-07-29
IL120443A (en) 2000-07-16
HK1003051A1 (en) 1998-10-09
NZ314406A (en) 2000-12-22
NO971219D0 (no) 1997-03-17
ATE212548T1 (de) 2002-02-15
NO313179B1 (no) 2002-08-26
DE69710111D1 (de) 2002-03-14
CZ79097A3 (en) 1997-10-15
US5753681A (en) 1998-05-19
ES2167678T3 (es) 2002-05-16
KR19980023975A (ko) 1998-07-06
KR100542778B1 (ko) 2006-04-14

Similar Documents

Publication Publication Date Title
NL350075I2 (es)
BG106586A (en) Pyrazolopyramidines as therapeutic agents
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
BG104631A (en) Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
CA2309350A1 (en) Purine derivatives and medicaments comprising the same as active ingredient
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
ES2187473T3 (es) Triarylimidazoles.
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
EP1156045A4 (en) AMID DERIVATIVES AND DRUG COMPOSITIONS
WO2000004014A1 (fr) Derives de pyrimidine manifestant une activite antitumorale
HK1107814A1 (en) Thiadiazoline derivatives for treating cancer
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
EP1243268A4 (en) MEDICINAL COMPOSITION
EP1284272A4 (en) Estra-1,3,5 (10) -triene
EP1201668A4 (en) STAUROSPORINE DERIVATIVES
EP0686636A4 (en) TRICYCLIC DERIVATIVES OF BENZAZEPINE AND BENZOTHIAZEPINE
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
ES2093091T3 (es) Derivado de glutation.
EP1130015A4 (en) PYRIDAZINONE DERIVATIVES
BG103735A (en) Method for the preparation of substituted thiazolidindions
CA2195031A1 (en) Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees